'First-in-class' precision cancer drug shows promising results in Phase I trial
A new drug targeting cancer’s ability to repair its DNA has shown promising results in a Phase I trial.
FOX NEWS: 'First-in-class' precision cancer drug shows promising results in Phase I trial
Wednesday, 24 June 2020
/ by'First-in-class' precision cancer drug shows promising results in Phase I trial
A new drug targeting cancer’s ability to repair its DNA has shown promising results in a Phase I trial.
Subscribe to:
Post Comments (Atom)
No comments
Post a Comment